Login / Signup

Robust Performance Metrics for Assessing Equitable Clinical Trial Participant Enrollment: Can We Get There?

Evangeline GreenJasmine R Marcelin
Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Keyphrases
  • clinical trial
  • health insurance
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • affordable care act
  • placebo controlled